Ospedale Ruber Internacional
Ospedale Ruber Internacional
Spagna, Madrid
Enrique Grande
21 anni di esperienza
Clinica certificata da :
| Turchia | Austria | Spagna | |
| Terapia protonica per il cancro alla prostata | da $30,000 | da $80,000 | da $70,000 |
| Terapia protonica per il cancro al seno | da $30,000 | da $55,000 | da $85,000 |
| Terapia con protoni | da $70,000 | da $80,000 | da $25,061 |
| Chemioterapia per carcinoma mammario | da $1,200 | da $15,000 | da $3,500 |
| Brachiterapia | da $3,465 | da $15,000 | da $10,000 |
Oltre 12.000 interventi laparoscopici eseguiti – Il Dott. Ballesta Lopez ha introdotto tecniche minimamente invasive presso il Centro Médico Teknon.
Dr. Enrique Grande, MD, PhD, MSc, is a medical oncologist with more than 20 years of experience. He is an international expert in genitourinary and neuroendocrine tumors. He directs the Medical Oncology Department and the One Oncology Madrid Cancer Program at QuirónSalud, Spain’s largest private healthcare network. He leads an integrated, multidisciplinary model with access to targeted therapies and clinical trials.
He is a pioneer in precision oncology. He uses molecular profiling and biomarker-based care. He has authored more than 300 peer-reviewed papers. He serves as a principal investigator and sits on steering committees for many international trials. These studies help set standards of care in urothelial bladder and neuroendocrine tumors. He contributes to guidelines and programs at ESMO, ASCO, ENETS, and EAU.
Il medico ha una vasta esperienza nel campo dell'oncologia peritoneale, attualmente lavora presso il Dipartimento di Carcinomatosi Peritoneale al Centro Médico Teknon in Spagna dal 2020 e presso il Dipartimento di Oncologia Peritoneale al Consorci Sanitari Integral dal 2010. In precedenza, il medico ha lavorato in chirurgia laparoscopica e robotica avanzata, nonché in chirurgia epatobiliare e pancreatica in vari ospedali prestigiosi in Spagna e Italia.<\/p>
Come esperto riconosciuto, il medico interviene frequentemente a congressi nazionali e internazionali sul trattamento chirurgico dei tumori addominali e pelvici avanzati e ha contribuito in modo significativo alla letteratura scientifica e agli studi clinici in chirurgia oncologica.<\/p>
Il medico è membro di diverse società chirurgiche e oncologiche stimate, tra cui GECOP, SEOQ, AEC, ESSO e PSOGI.<\/p>
International patients choose Spain for gallbladder cancer treatment due to exceptional survival rates and specialized surgical expertise. Spanish hospitals provide advanced therapies like Proteus ONE proton therapy and Da Vinci robotic surgery. Facilities often hold Joint Commission International accreditation and offer rapid access to multidisciplinary tumor boards.
Bookimed Expert Insight: While many countries offer robotic surgery, Spain stands out for combining specialized biliary expertise with high patient volumes. For example, Clinica Universidad de Navarra has treated over 700,000 international patients. This high volume across JCI-accredited centers creates a unique environment where rare gallbladder cases are treated as routine by multidisciplinary teams.
Patient Consensus: Patients value the speed of the Spanish private system, noting that scans and pathology reviews happen much faster than at home. Many survivors emphasize that having English-speaking staff and coordinator support makes managing complex oncology logistics manageable.
Spanish oncology centers like Centro Medico Teknon and Clinica Universidad de Navarra excel in treating gallbladder cancer. These facilities hold JCI accreditation and house specialized hepatobiliary surgical units. Leading Spanish experts use robotic surgery and proton therapy to manage complex biliary tract tumors effectively.
Bookimed Expert Insight: Data shows a major experience gap between general surgeons and specialists like Dr. Carlos Ballesta Lopez, who has over 45 years of experience. Patients often choose Teknon because his team handles gallbladder and pancreatic cases specifically, rather than general abdominal surgery. This focus is a key quality signal in Spain.
Patient Consensus: Patients note it is vital to find a center where hepatobiliary surgeons and GI oncologists work together daily. They emphasize confirming that the clinic regularly handles biliary tract cancers specifically instead of just general oncology cases.
Surgical options in Spain for early-stage gallbladder cancer include simple cholecystectomy for stage T1a tumors and extended radical resection for stages T1b or T2. Specialized hepatobiliary centers in Barcelona and Madrid prioritize R0 resection to achieve complete tumor removal and ensure curative results.
Bookimed Expert Insight: Spain ranks fourth globally in oncology requests on our platform. High patient volumes at centers like Centro Médico Teknon, which performs 23,500 operations annually, correlate with extensive surgical expertise. Dr. Carlos Ballesta Lopez at Teknon has performed over 12,000 procedures. This high-volume experience is crucial for complex hepatobiliary surgeries where precision determines long-term success.
Patient Consensus: Patients note it is important to confirm if a hepatobiliary specialist is leading the team. They also emphasize requesting a multidisciplinary tumor board review to verify the exact cancer stage.
Advanced or unresectable gallbladder cancer is managed with systemic treatments to slow tumor growth and relieve symptoms. Spanish oncology centers provide chemoimmunotherapy using gemcitabine, cisplatin, and durvalumab. Precision medicine through molecular profiling identifies targeted therapies for HER2 or BRAF mutations. Specialized proton therapy and palliative stenting are also available.
Bookimed Expert Insight: Spain hosts major research hubs like the Baselga Institute at Hospital Quiron Barcelona, where patients access treatments developed in collaboration with leading American centers. While many centers offer chemotherapy, only a few like Clinica Universidad de Navarra combine this with 70+ years of expertise in complex organ transplants and oncology. Patients with advanced stages should look for clinics with established molecular medicine labs to ensure their treatment is based on tumor genetics rather than a one-size-fits-all approach.
Patient Consensus: Patients note it is important to request genomic testing early to find targeted drug options. They also emphasize that getting a stent placed quickly is necessary to stop itching and proceed with chemotherapy.
International patients manage gallbladder cancer treatment in Spain through dedicated international departments at JCI-accredited centers. These teams coordinate medical visa support, pathology report translations, and multidisciplinary consultations. Facilities like Centro Medico Teknon and Clinica Universidad de Navarra provide comprehensive logistics for over 700,000 global patients.
Bookimed Expert Insight: While many choose Spain for standard surgery, the real advantage lies in integrated clinical trials and advanced radiotherapy. For example, Quironsalud Madrid offers free participation in clinical trials for specific cancer treatments. Additionally, proton therapy packages starting at $22,000 include extensive hotel stays because these procedures require no hospitalization.
Patient Consensus: Patients emphasize organizing a translated medical packet before arrival to avoid diagnostic delays. Many recommend bringing a Spanish-speaking companion or hiring an interpreter specifically for discharge instructions and consent forms.